Zanthoxylum chiloperone leaves extract: First sustainable Chagas disease treatment

Journal of Ethnopharmacology

Volumn 133, Issue 3, 2011, Pages 986-993

  Ferreira, Maria Elena ^a   Cebrián Torrejón, Gerardo ^b   Corrales, Alba Segovia ^a   Vera De Bilbao, Ninfa ^a   Rolón, Miriam ^c   Gomez, Celeste Vega ^c   Leblanc, Karine ^b   Yaluf, Gloria ^a   Schinini, Alicia ^a   Torres, Susana ^a   Serna, Elva ^a   Rojas De Arias, Antonieta ^c   Poupon, Erwan ^b   Fournet, Alain ^d  

^a UNIVERSIDAD NACIONAL DE ASUNCIÓN   (Paraguay)

^b UNIVERSITÉ PARIS SUD   (France)

^c CENTRO PARA EL DESARROLLO DE LA INVESTIGACIÓN CIENTÍFICA   (Paraguay)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Canthin 6 one; Chagas disease; Cytotoxicity; Experimental treatment; HPLC UV MS; Mutagenicity; Paraguay; Rutaceae; Zanthoxylum chiloperone

Indexed keywords

5 METHOXY CANTHIN 6 ONE; ANTIFUNGAL AGENT; ANTILEISHMANIAL AGENT; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; CANTHIN 6 ONE; PLANT EXTRACT; UNCLASSIFIED DRUG; ZANTHOXYLUM CHILOPERONE EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CHAGAS DISEASE; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG ISOLATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; PLANT LEAF; TRYPANOSOMA CRUZI; ULTRAVIOLET RADIATION; ZANTHOXYLUM;

MUS; RUTACEAE; TRYPANOSOMA CRUZI; ZANTHOXYLUM;

EID: 79551526472     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.11.032     Document Type: Article

References (27)

1. F.S. Buckner, C.L. Verlinde, A.C. La Flamme, and W.C. Van Voorhis Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase Antimicrobial and Agents Chemotherapy 40 1996 2592 2597
2. M.I. Cano, A. Gruber, A.M. Vazquez, A. Cortés, M.J. Levin, A. González, W. Degrave, E. Rondinelli, B. Zingales, J.L. Ramirez, C. Alonso, J.M. Requena, and J.F. Silveira Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi genome project Molecular and Biochemical Parasitology 71 1995 273 278
3. I.S. Caldas, A. Talvani, S. Caldas, C.M. Carneiro, M. de Lana, P.M. da Matta Guedes, and M.T. Bahia Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions Parasitology Research 103 2008 413 421
4. M. Carini, R.M. Facino, G. Aldini, M. Calloni, and L. Colombo Characterization of phenolic antioxidants from Mate (Illex Paraguayensis) by liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry Rapid Communication in Mass Spectrometry 12 1998 1813 1819
5. H. Cerecetto, and M. Gonzalez Chemotherapy of Chagas' disease: status and new developments Current Topics in Medicinal Chemistry 2 2002 1187 1213
6. E. Chiari, A.B. Oliveira, M.A.F. Prado, R.J. Alves, L.M.C. Galva, and F.G. Araujo Potential use of WR6026 as prophylaxis against transfusion- transmitted American trypanosomiasis Antimicrobial Agents and Chemotherapy 40 1996 613 615
7. A.L. de Andrade, F. Zicker, R.M. de Oliveira, S. Almeida Silva, A. Luquetti, L.R. Travassos, I.C. Almeida, S.S. de Andrade, J.G. de Andrade, and C.M. Martelli Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection Lancet 348 1996 1407 1413
8. Ferreira, M.E., Fournet, A., Rojas de Arias, A., Hocquemiller, R., Poupon, E., 2002a. Use of canthin-6-one, plant extracts containing same and derivatives thereof for the treatment of trypanosomiasis. Patent PCT/FR2003/003459.
9. M.E. Ferreira, A. Rojas de Arias, S. Torres de Ortiz, A. Inchausti, H. Nakayama, C. Thouvenel, R. Hocquemiller, and A. Fournet Leishmanicidal activity of canthin-6-one alkalloids isolated from Zanthoxylum chiloperone var. angustifolium Journal of Ethnopharmacology 80 2002 199 202
10. M.E. Ferreira, H. Nakayama, A. Rojas de Arias, A. Schinini, N. Vera de Bilbao, E. Serna, S. Torres de Ortiz, L. Sanabria, D. Lagoutte, F. Soriano-Agatón, E. Poupon, R. Hocquemiller, and A. Fournet Effects of alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice Journal of Ethnopharmacology 109 2007 258 263
11. J.A. Heddle A rapid in vivo test for chromosomal damage Mutation Research 18 1973 187 190
12. D. Lagoutte, V. Nicolas, E. Poupon, A. Fournet, R. Hocquemiller, D. Libong, P. Chaminade, and P.M. Loiseau Antifungal canthin-6-one series accumulate in lipid droplets and affect fatty acid metabolism in Saccharomyces cerevisiae Biomedicine and Pharmacotherapy 62 2008 99 103
13. J. Molina, Z. Brener, A.J. Romanha, and J.A. Urbina In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi Journal of Antimicrobial Chemotherapy 46 2000 137 140
14. N. Nuengchamnong, K. Krittasilp, and K. Ingkaninan Rapid screening and identification of antioxidants in aqueous extracts of Houttuynia cordata using LC-ESI-MS coupled with DPPH assay Food Chemistry 117 2009 750 756
15. A. Rassi Jr., A. Rassi, and J.A. Marin-Neto Chagas disease Lancet 375 2010 1388 1402
16. I. Ribeiro, A.M. Sevcsik, F. Alves, G. Diap, R. Don, M.O. Harhay, S. Chang, and B. Pecoul New, improved treatments fro Chagas disease: from the R & D pipeline to the patients PLoS Neglected Tropical Diseases 3 2009 e4841, 1-6
17. M. Rolon, E.M. Seco, C. Vega, C. Nogal, J.J. Nogal, J.A. Escario, A. Gomez-Barrio, and F. Malpartida Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi International Journal of Antimicrobial Agents 28 2006 104 109
18. W. Schimid The micronucleus test Mutation Research 31 1975 9 15
19. F. Soriano-Agaton, D. Lagoutte, E. Poupon, F. Roblot, A. Fournet, J.C. Gantier, and R. Hocquemiller Extraction, hemisynthesis, and synthesis of canthin-6-one analogues. Evaluation of their antifungal activities Journal of Natural Products 68 2005 1581 1587
20. Spichiger, R., Stutz de Ortega, L., 1987. Flora del Paraguay: Rutaceae. Ed. Conservatoire et Jardin botaniques de la Ville de Genve, Missouri Botanical Garden, pp. 19-36.
21. C. Thouvenel, J.C. Gantier, P. Duret, C. Fourneau, R. Hocquemiller, M.E. Ferreira, A. Rojas de Arias, and A. Fournet Antifungal compounds from Zanthoxylum chiloperone var. angustifolium Phytotherapy Research 17 2003 678 680
22. J.A. Urbina Chemotherapy of Chagas disease Current Pharmaceutical Design 8 2002 287 295
23. J.A. Urbina, G. Payares, C. Sanoja, R. Lira, and A.J. Romanha In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease International Journal of Antimicrobial Agents 21 2003 27 38
24. J.A. Urbina, G. Payares, C. Sanoja, J. Molina, R. Lira, Z. Brener, and A.J. Romanha Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains International Journal of Antimicrobial Agents 21 2003 39 48
25. V.M. Veloso, C.M. Carneiro, M.J.O. Toledo, M. de Lana, E. Chiari, W.L. Tafuri, and M.T. Bahia Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains Memorias do Instituto Oswaldo Cruz 96 2001 1005 1011
26. D. Villareal, C. Barnabé, D. Sereno, and M. Tibayrenc Lack of corrélation between in vitro susceptibility to benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease Experimental Parasitology 108 2004 24 31
27. World Health Organization, 2002. Control of Chagas Disease, Technical Reports. Ser. 2905, 1-109.